Day: May 29, 2024

AMSC Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Outlook

Business Highlights: Full year revenues increased over 37% year over year to $145.6 million Full year gross margin expansion of 1,620 basis points over the prior year Generated $2.1 million of operating cash flow, helping to further strengthen the balance sheet Company to host conference call tomorrow, May 30 at 10:00 am ET AYER, Mass., May 29, 2024 (GLOBE NEWSWIRE) — AMSC (Nasdaq: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™, and that protect and expand the capability and resiliency of our Navy’s fleet, today reported financial results for its fourth quarter and fiscal year ended March 31, 2024 (“fiscal 2023”). Revenues for the fourth quarter of fiscal 2023 were $42.0 million compared with $31.7 million for the same...

Continue reading

HP Inc. Reports Fiscal 2024 Second Quarter Results

PALO ALTO, Calif., May 29, 2024 (GLOBE NEWSWIRE) — HP (NYSE: HPQ) Second quarter GAAP diluted net earnings per share (“EPS”) of $0.61, within the previously provided outlook of $0.58 to $0.68 per share Second quarter non-GAAP diluted net EPS of $0.82, within the previously provided outlook of $0.76 to $0.86 per share Second quarter net revenue of $12.8 billion, down 0.8% from the prior-year period Second quarter net cash provided by operating activities of $0.6 billion, free cash flow of $0.5 billion Second quarter returned $0.4 billion to shareholders in the form of dividends and share repurchases   HP Inc.’s fiscal 2024 second quarter financial performance   Q2 FY24 Q2 FY23 Y/Y GAAP net revenue ($B) $ 12.8   $ 12.9   (0.8)% GAAP operating margin   7.4%     5.8%   1.6 pts GAAP net earnings ($B) $ 0.6   $ 1.1   (42)% GAAP...

Continue reading

Credo Technology Group Holding Ltd Reports Fourth Quarter and Fiscal Year 2024 Financial Results

SAN JOSE, Calif., May 29, 2024 (GLOBE NEWSWIRE) — Credo Technology Group Holding Ltd (Nasdaq: CRDO) (“Credo”), an innovator in providing secure, high-speed connectivity solutions that deliver improved energy efficiency, today reported financial results for the fourth quarter and full fiscal year 2024, ended April 27, 2024. Fourth Quarter of Fiscal Year 2024 Financial Highlights Revenue of $60.8 million grew by 89.4% year over year GAAP gross margin of 65.8% and non-GAAP gross margin of 66.1%   GAAP operating expenses of $47.8 million and non-GAAP operating expenses of $32.7 million GAAP net loss of $10.5 million and non-GAAP net income of $11.8 million GAAP diluted net loss per share of $0.06 and non-GAAP diluted net income per share of $0.07 Ending cash and short-term investment balance of $410.0 million Management Commentary Bill...

Continue reading

nCino Reports First Quarter Fiscal Year 2025 Financial Results

• Total Revenues of $128.1M, up 13% year-over-year • Subscription Revenues of $110.4M, up 13% year-over-year • GAAP Operating Margin of (3)%, up ~500 basis points year-over-year • Non-GAAP Operating Margin of 19%, up ~900 basis points year-over-year WILMINGTON, N.C., May 29, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced financial results for the first quarter of fiscal year 2025, ended April 30, 2024. “Building on our fourth quarter momentum, we had a great start to the year, achieving our highest first-quarter gross sales in Company history,” said Pierre Naudé, Chairman and CEO at nCino. “Our strong sales execution produced wins across multiple markets, highlighting the breadth and depth of our product portfolio and the effectiveness...

Continue reading

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024

Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic areas over this fiscal year ending March 31, 2025 Topline data from the batoclimab Myasthenia Gravis (MG) study is also expected over this fiscal year and further potentially registrational development in MG with IMVT-1402 is expected to begin in the same timeframe Immunovant has decided to run the batoclimab trial in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) longer prior to unblinding period 1 in order to better ensure that the data from the batoclimab trial, combined with learning from other CIDP trials, can be used to optimize the IMVT-1402 CIDP trial design  Detailed results from the batoclimab study in...

Continue reading

Nokia Corporation: Repurchase of own shares on 29.05.2024

Nokia CorporationStock Exchange Release29 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 29.05.2024 Espoo, Finland – On 29 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* XHEL 429,773 3.50 CEUX – – BATE – – AQEU – – TQEX – – Total 429,773 3.50 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

VEON appoints UHY LLP as auditors for VEON Group’s 2023 PCAOB Audit and shares compliance plan with Nasdaq

Amsterdam, 29 May 2024 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, (“VEON” or the “Company” or, together with its subsidiaries, the “Group”), announces that it has appointed UHY LLP (UHY) as the independent registered public accounting firm for the audit of the Group’s consolidated financial statements for the year ended December 31, 2023 in accordance with the standards established by the Public Company Accounting Oversight Board (United States) (the “PCAOB Audit”).   As previously announced, VEON experienced a delay in filing its 2023 annual report on Form 20-F (the “2023 20-F”) due to the challenges it faced in connection with the timely appointment of an independent auditor that meets the requirements for a PCAOB audit following VEON’s...

Continue reading

Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool

Published open-access today in Nature Genetics, “High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing” identifies novel evidence of a proximity bias in CRISPR-Cas9 gene knockouts and a debiasing (correcting) algorithm. SALT LAKE CITY, May 29, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today published in Nature Genetics scientific findings that highlights a potential limitation of CRISPR-Cas9 in gene editing – a key component in understanding disease mechanisms, and developing new therapeutic approaches. This proximity bias, discoverable through Recursion’s proprietary biological dataset, could have many downstream impacts on the community’s ability to make meaningful progress...

Continue reading

Toll Brothers Honored at the Best in Pennsylvania Living Awards

Company wins awards including Townhome Community of the Year for Overlook at Town Center and Single-Family Home Community of the Year for Stonebrook at Upper Merion – Heritage Collection FT. WASHINGTON, Pa., May 29, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the Company’s Pennsylvania Division was honored with multiple awards at the 2024 Best in Pennsylvania Living Awards, recently held at The Alloy Hotel in King of Prussia, Pennsylvania. Presented by the Home Builder’s Association of Bucks and Montgomery Counties and Home Builder’s Association of Chester and Delaware Counties, the Best in Pennsylvania Living Awards is a best-in-class competition recognizing excellence for home building, design, and associate services. The Toll Brothers Pennsylvania Division...

Continue reading

Automotive Finco Corp. Files Condensed Interim Consolidated Financial Statements for the three months ended March 31, 2024

Not for distribution to United States newswire services or for dissemination in the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. TORONTO, May 29, 2024 (GLOBE NEWSWIRE) — Automotive Finco Corp. (NEX: AFCC-H) (the “Company”) today announced that it has filed condensed interim consolidated financial statements for the three months ended March 31, 2024. The statements together with the Management Discussion and Analysis can be found on the Company’s SEDAR+ profile at www.sedarplus.ca. About Automotive Finco Corp. Automotive Finco Corp. is a finance company focused exclusively on the auto retail sector. In addition to its interest in Automotive Finance Limited Partnership, the Company may also pursue other direct investments and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.